期刊
PHARMACEUTICS
卷 14, 期 12, 页码 -出版社
MDPI
DOI: 10.3390/pharmaceutics14122719
关键词
blood-brain barrier; transcytosis; nanocarriers; nose-to-brain delivery; exosome; peptide
资金
- Department of Pharmaceuticals, Ministry of Chemicals and Fertilizers, India
- Department of Science and Technology, Government of India
- Core Research Grant funding in Tekade's Laboratory [ECR/2016/001964]
- Indian Council of Medical Research (ICMR), New Delhi [CRG/2021/005402]
- [2021-14161]
This article discusses the limitations of the blood-brain barrier (BBB) on brain drug delivery and ways to overcome it using new techniques such as nanomedicine, nose-to-brain drug delivery, and peptides as drug delivery carriers. It also helps to understand the factors affecting BBB permeability and the body clearance of drugs delivered to the brain.
It is well known that the presence of a blood-brain barrier (BBB) makes drug delivery to the brain more challenging. There are various mechanistic routes through which therapeutic molecules travel and deliver the drug across the BBB. Among all the routes, the transcellular route is widely explored to deliver therapeutics. Advances in nanotechnology have encouraged scientists to develop novel formulations for brain drug delivery. In this article, we have broadly discussed the BBB as a limitation for brain drug delivery and ways to solve it using novel techniques such as nanomedicine, nose-to-brain drug delivery, and peptide as a drug delivery carrier. In addition, the article will help to understand the different factors governing the permeability of the BBB, as well as various formulation-related factors and the body clearance of the drug delivered into the brain.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据